• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A rare presentation of the diffuse dermal mucinosis in adenocarcinoma of the lungs treated with pembrolizumab and pemetrexed.

作者信息

Koch Karen, Solanki Kamal, Zhu Julia

机构信息

Te Whatu Ora Health Waikato, Waikato Hospital, Hamilton, New Zealand.

Waikato School of Medicine, Auckland University, Hamilton, New Zealand.

出版信息

JAAD Case Rep. 2025 Apr 27;61:21-25. doi: 10.1016/j.jdcr.2025.04.014. eCollection 2025 Jul.

DOI:10.1016/j.jdcr.2025.04.014
PMID:40535966
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12173707/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981f/12173707/0549c102df2d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981f/12173707/08498349a68f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981f/12173707/02cabb69bdff/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981f/12173707/434ae377bcb4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981f/12173707/0549c102df2d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981f/12173707/08498349a68f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981f/12173707/02cabb69bdff/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981f/12173707/434ae377bcb4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981f/12173707/0549c102df2d/gr4.jpg

相似文献

1
A rare presentation of the diffuse dermal mucinosis in adenocarcinoma of the lungs treated with pembrolizumab and pemetrexed.在用派姆单抗和培美曲塞治疗的肺腺癌中弥漫性皮肤粘蛋白病的罕见表现。
JAAD Case Rep. 2025 Apr 27;61:21-25. doi: 10.1016/j.jdcr.2025.04.014. eCollection 2025 Jul.
2
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.新辅助和辅助帕博利珠单抗治疗局部晚期头颈癌
N Engl J Med. 2025 Jul 3;393(1):37-50. doi: 10.1056/NEJMoa2415434. Epub 2025 Jun 18.
3
Longitudinally extensive transverse myelitis after pembrolizumab and lenvatinib therapy for a rare subtype of renal cell carcinoma: A case report.帕博利珠单抗和乐伐替尼治疗罕见亚型肾细胞癌后发生的纵向广泛横贯性脊髓炎：一例报告
Oncol Lett. 2025 Jun 5;30(2):386. doi: 10.3892/ol.2025.15132. eCollection 2025 Aug.
4
First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia.一线帕博利珠单抗联合阿昔替尼与舒尼替尼治疗转移性肾细胞癌：东亚地区3期KEYNOTE-426研究入组患者的亚组分析
Jpn J Clin Oncol. 2025 Apr 6;55(4):406-413. doi: 10.1093/jjco/hyae182.
5
The Treatment of Pembrolizumab-Induced Pruritus with Topical Roflumilast Cream 0.3% Once Daily.每日一次外用0.3%罗氟司特乳膏治疗帕博利珠单抗引起的瘙痒
J Clin Aesthet Dermatol. 2025 May 1;18(5):36-37.
6
Survival Outcomes of Lung Adenocarcinoma With Intestinal Differentiation in the Era of Immunotherapy.免疫治疗时代伴有肠化生的肺腺癌的生存结局
JTO Clin Res Rep. 2025 Mar 20;6(7):100827. doi: 10.1016/j.jtocrr.2025.100827. eCollection 2025 Jul.
7
Comparative effectiveness of pembrolizumab-chemotherapy versus chemotherapy with/without bevacizumab in unresectable, locally advanced or metastatic non-small cell lung cancer: a Chinese multicenter real-world analysis emphasizing PD-L1-negative populations.帕博利珠单抗联合化疗与含或不含贝伐单抗化疗在不可切除的局部晚期或转移性非小细胞肺癌中的疗效比较：一项强调PD-L1阴性人群的中国多中心真实世界分析
Transl Lung Cancer Res. 2025 May 30;14(5):1804-1820. doi: 10.21037/tlcr-2025-271. Epub 2025 May 27.
8
A randomized comparative study on maintenance gemcitabine versus supportive care in pleural mesothelioma.一项关于培美曲塞维持治疗对比支持治疗在胸膜间皮瘤中的随机对照研究。 （你提供的原文中药物名称有误，正确的应该是培美曲塞，英文是pemetrexed ，而不是gemcitabine ，gemcitabine是吉西他滨 。我按照正确的信息进行了准确翻译，若你有特殊要求，请随时告知。）
Future Oncol. 2025 Jul;21(17):2203-2213. doi: 10.1080/14796694.2025.2516412. Epub 2025 Jun 12.
9
MS-stable/TMB-high pleomorphic liposarcoma successfully treated with pembrolizumab: a case report.帕博利珠单抗成功治疗微卫星稳定/肿瘤突变负荷高的多形性脂肪肉瘤：一例报告
Front Oncol. 2025 Jun 3;15:1552411. doi: 10.3389/fonc.2025.1552411. eCollection 2025.
10
Continuous remission of single-mode therapy with pembrolizumab plus chemotherapy in locally advanced hypopharyngeal carcinoma: a case report.帕博利珠单抗联合化疗单模式疗法使局部晚期下咽癌持续缓解：一例报告
Front Immunol. 2025 Jun 5;16:1557565. doi: 10.3389/fimmu.2025.1557565. eCollection 2025.

本文引用的文献

1
Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome with Pembrolizumab for Lung Squamous Cell Carcinoma.帕博利珠单抗治疗肺鳞癌致缓解性血清阴性对称性滑膜炎伴凹陷性水肿综合征。
Intern Med. 2024 Jul 15;63(14):2089-2096. doi: 10.2169/internalmedicine.2475-23. Epub 2023 Dec 11.
2
Paraneoplastic morphea with prominent mucin deposition.伴有显著黏液沉积的副肿瘤性硬斑病
JAAD Case Rep. 2023 Sep 26;41:110-112. doi: 10.1016/j.jdcr.2023.09.015. eCollection 2023 Nov.
3
Edema of the face and extremities secondary to pemetrexed.
培美曲塞所致的面部及四肢水肿。
JAAD Case Rep. 2023 May 18;38:20-22. doi: 10.1016/j.jdcr.2023.05.011. eCollection 2023 Aug.
4
Scleredema Adultorum of Buschke Associated With Diffuse Eosinophilia and Hepatitis B Virus Infection.与弥漫性嗜酸性粒细胞增多和乙型肝炎病毒感染相关的布希克成人硬肿病
Cureus. 2023 Apr 29;15(4):e38300. doi: 10.7759/cureus.38300. eCollection 2023 Apr.
5
Scleredema with biopsy-confirmed cardiomyopathy: A case report.
J Scleroderma Relat Disord. 2021 Oct;6(3):311-315. doi: 10.1177/23971983211013977. Epub 2021 May 12.
6
New and emerging conditions of acquired cutaneous mucinoses in adults.成人获得性皮肤黏蛋白病的新出现和新兴情况。
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):1016-1024. doi: 10.1111/jdv.17983. Epub 2022 Feb 17.
7
Diffuse dermal mucinosis secondary to colony-stimulating factor 1 receptor monoclonal antibody treatment: A novel and peculiar drug-induced diffuse cutaneous mucinosis.
J Dermatol. 2021 Mar;48(3):380-384. doi: 10.1111/1346-8138.15662. Epub 2020 Nov 20.
8
Diffuse edema suggestive of cytokine release syndrome in a metastatic lung carcinoma patient treated with pembrolizumab.在接受帕博利珠单抗治疗的转移性肺癌患者中出现提示细胞因子释放综合征的弥漫性水肿。
Immunotherapy. 2017 Mar;9(4):309-311. doi: 10.2217/imt-2016-0134.
9
Scleredema. A multicentre study of characteristics, comorbidities, course and therapy in 44 patients.硬化性水肿。44例患者特征、合并症、病程及治疗的多中心研究。
J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2399-404. doi: 10.1111/jdv.13272. Epub 2015 Aug 24.
10
Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema.丘疹性黏蛋白病、黏液性苔藓和硬化性黏液水肿的更新分类。
J Am Acad Dermatol. 2001 Feb;44(2):273-81. doi: 10.1067/mjd.2001.111630.